Cargando…
Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy
Community-acquired bacterial pneumonia (CABP) is a leading cause of death worldwide. However, antibacterial agents used to treat common pathogens in CABP are marked by adverse drug events and increasing antimicrobial resistance. Solithromycin is a new ketolide antibiotic, based on the macrolide anti...
Autores principales: | Donald, Bryan J, Surani, Salim, Deol, Harmeet S, Mbadugha, Uche J, Udeani, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732564/ https://www.ncbi.nlm.nih.gov/pubmed/29263651 http://dx.doi.org/10.2147/DDDT.S119545 |
Ejemplares similares
-
Antimicrobial Therapy for Pneumonia or Fluid Overload?
por: Mbadugha, Uche J, et al.
Publicado: (2021) -
Inter-rater Reliability of the Ramsay Sedation Scale for Critically-ill Intubated Patients
por: Deol, Harmeet S, et al.
Publicado: (2019) -
Clinical and Economic Impact of Rapid Blood Pathogen Identification Via Verigene
por: Ngo, Hoa, et al.
Publicado: (2022) -
A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy
por: Keelan, Jeffrey A., et al.
Publicado: (2016) -
In Vitro Activity of Solithromycin against Bordetella pertussis, an Emerging Respiratory Pathogen
por: Hardy, Dwight J., et al.
Publicado: (2016)